This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 11-14, 2026
Hynes Convention CenterBoston, MA

Tobias Kapp, PhD
Global Head of Peptide Development at Corden Pharma
Speaker

Profile

Tobias Kapp is the Global Head Peptide Development at Corden Pharma. In this role he oversees the development activities on all of Corden`s Peptide sites and works closely at the interface of development and scale up for all process stages for both solid phase and liquid phase processes. Additionally, he is involved in the evaluation and implementation of new and innovative technologies. He is an organic and peptide chemist by training and earned his PhD under the supervision of Prof. Kessler at the Technical University of Munich where he worked on the development and medicinal application of subtype selective peptide ligands for integrins and CXCR4. After his PhD he started his career in the peptide CDMO industry, where he worked in scale up development of up- and downstream SPPS processes hands on and later in different leadership roles.

Agenda Sessions

  • Accelerate Timeline to Start PhI: Phase Appropriate Development and Integrated Drug Product Supply

    12:20pm